; (III) the reasons why other medications described in paragraph (4) were not included; and (IV) which critical medications are designated critical medications under subsection (b) and the reasons for each such designation; and (iii) make publicly available the list in effect under paragraph (1) and the most recent report under clause (ii), subject to any redactions or edits necessary to remove classified information or otherwise ensure that national security is not compromised; and (B) not later than March 15 of each year following the year in which the first list of critical medications is required by paragraph (1)— (i) update the list required by paragraph (1); (ii) submit an updated report under subparagraph (A)(ii)